Mazdutide
Research PhaseMazdutide (IBI362)
- Category
- Weight Loss & Metabolism
- Aliases
- IBI362
- Administration
- Subcutaneous injection
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
- 2
3–4 Weeks
Fullness after smaller meals tends to become more consistent as the dose is titrated.
- 3
5–7 Weeks
Early, gradual weight changes may begin to be noticed.
- 4
8–10 Weeks
Continued appetite and weight changes are typical through this period.
- 5
11–15 Weeks
Sustained weight loss trends are generally reported through this window in available data.
- 6
16–20 Weeks
This stage is commonly described as when body composition changes become clearly visible.
- 7
21–24 Weeks
Many users in markets where it's approved are approaching a maintenance phase by this stage.
⚠️ Research context only. This is not medical advice and results are not guaranteed.